全文获取类型
收费全文 | 1368篇 |
免费 | 213篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 29篇 |
妇产科学 | 37篇 |
基础医学 | 125篇 |
口腔科学 | 43篇 |
临床医学 | 237篇 |
内科学 | 333篇 |
皮肤病学 | 9篇 |
神经病学 | 159篇 |
特种医学 | 18篇 |
外科学 | 134篇 |
综合类 | 8篇 |
一般理论 | 1篇 |
预防医学 | 246篇 |
眼科学 | 18篇 |
药学 | 66篇 |
肿瘤学 | 109篇 |
出版年
2024年 | 5篇 |
2023年 | 41篇 |
2022年 | 23篇 |
2021年 | 41篇 |
2020年 | 45篇 |
2019年 | 35篇 |
2018年 | 59篇 |
2017年 | 64篇 |
2016年 | 66篇 |
2015年 | 43篇 |
2014年 | 67篇 |
2013年 | 87篇 |
2012年 | 88篇 |
2011年 | 69篇 |
2010年 | 61篇 |
2009年 | 66篇 |
2008年 | 66篇 |
2007年 | 73篇 |
2006年 | 64篇 |
2005年 | 64篇 |
2004年 | 54篇 |
2003年 | 42篇 |
2002年 | 37篇 |
2001年 | 51篇 |
2000年 | 31篇 |
1999年 | 17篇 |
1998年 | 18篇 |
1997年 | 10篇 |
1996年 | 19篇 |
1995年 | 14篇 |
1994年 | 10篇 |
1993年 | 16篇 |
1992年 | 13篇 |
1991年 | 10篇 |
1990年 | 9篇 |
1989年 | 12篇 |
1988年 | 4篇 |
1987年 | 13篇 |
1986年 | 9篇 |
1985年 | 5篇 |
1984年 | 8篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1979年 | 7篇 |
1978年 | 2篇 |
1977年 | 2篇 |
1975年 | 2篇 |
1968年 | 4篇 |
1967年 | 3篇 |
1945年 | 6篇 |
排序方式: 共有1582条查询结果,搜索用时 15 毫秒
31.
Christopher G. Goetz MD Glenn T. Stebbins PhD Kathryn A. Chung MD Robert A. Hauser MD MBA Janis M. Miyasaki MD Anthony P. Nicholas MD PhD Werner Poewe MD Klaus Seppi MD Olivier Rascol MD PhD Mark A. Stacy MD John G. Nutt MD Caroline M. Tanner MD PhD Alison Urkowitz MPA Jean A. Jaglin RN Song Ge MS 《Movement disorders》2013,28(3):341-346
Numerous scales assess dyskinesia in Parkinson's disease (PD), variably focusing on anatomical distribution, phenomenology, time, severity, and disability. No study has compared these scales and their relative ability to detect change related to an established treatment. We conducted a randomized placebo‐controlled trial of amantadine, assessing dyskinesia at baseline and at 4 and 8 weeks using the following scales: Unified Dyskinesia Rating Scale (UDysRS), Lang‐Fahn Activities of Daily Living Dyskinesia Rating Scale (LF), 26‐Item Parkinson's Disease Dyskinesia scale (PDD‐26), patient diaries, modified Abnormal Involuntary Movements Scale (AIMS), Rush Dyskinesia Rating Scale (RDRS), dyskinesia items from the Movement Disorder Society–sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS), and Clinical Global Impression (severity and change: CGI‐S, CGI‐C). Scale order was randomized at each visit, but raters were aware of each scale as it was administered. Sensitivity to treatment was assessed using effect size. Sixty‐one randomized dyskinetic PD subjects (31 amantadine, 30 placebo) completed the study. Four of the 8 scales (CGI‐C, LF, PDD‐26, and UDysRS) detected a significant treatment. The UDysRS Total Score showed the highest effect size (η2 = 0.138) for detecting treatment‐related change, with all other scales having effect sizes < 0.1. No scale was resistant to placebo effects. This study resolves 2 major issues useful for future testing of new antidyskinesia treatments: among tested scales, the UDysRS, having both subjective and objective dyskinesia ratings, is superior for detecting treatment effects; and the magnitude of the UDysRS effect size from amantadine sets a clear standard for comparison for new agents. © 2012 Movement Disorder Society 相似文献
32.
33.
34.
Simon Driver Ann Marie Warren Megan Reynolds Stephanie Agtarap Rita Hamilton Zina Trost Kimberly Monden 《The journal of spinal cord medicine》2016,39(1):77-84
Objectives
To identify (1) changes in psychosocial factors, (2) relationships between psychosocial factors, and (3) significant predictors of resilience in adults with spinal cord injury (SCI) during inpatient rehabilitation and at 3-month post-discharge.Design
Cross sectional with convenience sample based on inclusion/exclusion criteria.Setting
Inpatient rehabilitation hospital and community-based follow-up.Participants
Individuals with a SCI.Interventions
Not applicable.Outcome measures
Demographic, resilience, self-efficacy for managing a chronic health issue, depression, social roles/activity limitations, and pain.Results
The final sample consisted of 44 respondents (16 women and 28 men). Results of repeated measure analyses of variance indicated no significant changes in variables between inpatient and 3-month follow-up. Bivariate correlations revealed associations between resilience and self-efficacy at inpatient (r = 0.54, P < 0.001), and resilience and depression (r = −0.69, P < 0.001) and self-efficacy (r = 0.67, P < 0.001) at 3-month follow-up. Hierarchical regression analyses a significant model predicting resilience at inpatient stay (R = 0.61; adjusted R2 = 0.24, P = 0.023), and at 3-month follow-up (R = 0.83; adjusted R2 = 0.49, P = 0.022). Self-efficacy was the strongest predictor at inpatient stay (β = 0.46, P = 0.006) and depression was strongest at 3-month follow-up (β = −0.80, P = 0.007).Conclusion
Results suggest that although resilience appears to be stable from inpatient to 3-month follow-up, different factors are stronger predictors of resilience across time. Based on current results, an assessment of self-efficacy during inpatient rehabilitation and an identification of depression at 3-month follow-up may be important factors to help identify those at risk of health issues overtime. 相似文献35.
36.
Vickie R. Driver Kara S. Couch Kristen A. Eckert Gary Gibbons Lorena Henderson John Lantis Eric Lullove Paul Michael Richard F. Neville Lee C. Ruotsi Robert J. Snyder Fadi Saab Marissa J. Carter 《Wound repair and regeneration》2022,30(1):7-23
In the wake of the coronavirus pandemic, the critical limb ischemia (CLI) Global Society aims to develop improved clinical guidance that will inform better care standards to reduce tissue loss and amputations during and following the new SARS-CoV-2 era. This will include developing standards of practice, improve gaps in care, and design improved research protocols to study new chronic limb-threatening ischemia treatment and diagnostic options. Following a round table discussion that identified hypotheses and suppositions the wound care community had during the SARS-CoV-2 pandemic, the CLI Global Society undertook a critical review of literature using PubMed to confirm or rebut these hypotheses, identify knowledge gaps, and analyse the findings in terms of what in wound care has changed due to the pandemic and what wound care providers need to do differently as a result of these changes. Evidence was graded using the Oxford Centre for Evidence-Based Medicine scheme. The majority of hypotheses and related suppositions were confirmed, but there is noticeable heterogeneity, so the experiences reported herein are not universal for wound care providers and centres. Moreover, the effects of the dynamic pandemic vary over time in geographic areas. Wound care will unlikely return to prepandemic practices. Importantly, Levels 2–5 evidence reveals a paradigm shift in wound care towards a hybrid telemedicine and home healthcare model to keep patients at home to minimize the number of in-person visits at clinics and hospitalizations, with the exception of severe cases such as chronic limb-threatening ischemia. The use of telemedicine and home care will likely continue and improve in the postpandemic era. 相似文献
37.
38.
39.
Mary Murray-Weir PT MBA Steven Magid MD CMIO Laura Robbins DSW Patricia Quinlan PhD MPA RN CPHQ Pamela Sanchez-Villagomez MPA Steven H. Shaha PhD DBA 《HSS journal》2014,10(1):52-58
Background
Computerized provider order entry (CPOE) has been considered essential for the reduction of medical errors and increased patient safety. Assessment of staff perception regarding a CPOE system is important for satisfaction and adoption. Incorporation of user feedback can greatly improve the functionality of a system and promote user satisfaction.Questions/Purposes
This study aims to develop an informatics staff satisfaction survey instrument and to understand what components of computerized prescriber order entry (CPOE) contribute to staff satisfaction and its variability over time.Methods
The 22-question survey was developed by a multidisciplinary group and focused on patient data including demographics, orders, medications, laboratory, and radiology data. The questions were designed to understand if clinicians (1) could easily access the information needed to properly take care of patients, (2) could act upon the information once acquired, (3) could obtain the information clearly, and (4) were alerted to potential errors. The survey was distributed just prior to “go-live,” 6 and 12 months after go-live. Responses were given on a five-point Likert scale.Results
The survey results post-implementation showed user satisfaction with CPOE. Satisfaction regarding the ease of obtaining orders, medication, and lab data had a significant improvement at 6 and 12 months post-implementation, p < 0.001. Satisfaction that the computerized order entry system provided information needed to take care of their patients improved, p < 0.01. At 1 year post-implementation, user satisfaction declined from 6 months earlier but still demonstrated an overall increase in satisfaction from pre-implementation.Conclusion
Compared prior to go-live, clinicians are satisfied or very satisfied across multiple spheres and multiple disciplines. At all time points, clinicians were able to obtain information required to take care of their patients. However, post-go-live, it was easier to obtain and act upon as well as more clear and understandable.Electronic supplementary material
The online version of this article (doi:10.1007/s11420-013-9377-1) contains supplementary material, which is available to authorized users. 相似文献40.